Skip to content
healthcare.dev

Senna

NDC 71399-1017, Sennosides, tablet, from Akron Pharma Inc..

Product NDC
71399-1017
Status
Listed
Labeler
Akron Pharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M007
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71399-1017 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SENNOSIDES8.6 mg/1
Package NDCNDC-11Package
71399-1017-171399101701100 TABLET in 1 BOTTLE (71399-1017-1)
71399-1017-2713991017021000 TABLET in 1 BOTTLE (71399-1017-2)
71399-1017-371399101703100 PACKET in 1 PACKAGE (71399-1017-3) / 1 TABLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 71399-1017 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71399-1017 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71399-1017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.